These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8777981)

  • 21. Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis.
    Yoshida T; Koga H; Saitoh F; Sakamoto M; Harada M; Yoshida H; Sakisaka S; Sata M
    Intern Med; 1999 Sep; 38(9):733-8. PubMed ID: 10480306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
    Bonapace CR; Mays DA
    Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary manifestations in antisynthetase syndrome.
    Ben Salem T; Abdelkafi C; Lamloum M; Ben Ghorbel I; Houman MH
    Tunis Med; 2018 Feb; 96(2):101-106. PubMed ID: 30324974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapsing tubulointerstitial nephritis in an adolescent with inflammatory bowel disease without aminosalicylate exposure.
    Shahrani Muhammad HS; Peters C; Casserly LF; Dorman AM; Watts M
    Clin Nephrol; 2010 Mar; 73(3):250-2. PubMed ID: 20178728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease.
    Casanova MJ; Chaparro M; Valenzuela C; Cisneros C; Gisbert JP
    World J Gastroenterol; 2015 Feb; 21(7):2260-2. PubMed ID: 25717268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pentasa (mesalazine) and pregnancy].
    Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
    Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N; Quartuccio L; De Marchi G; De Vita S
    Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of idiopathic inflammatory myopathy and Crohn's disease.
    Szabo N; Lukacs S; Kulcsar I; Gunasekera W; Nagy-Toldi A; Dezso B; Danko K
    Clin Rheumatol; 2009 Jan; 28(1):99-101. PubMed ID: 19002546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary manifestations of Sjögren's syndrome.
    Shi JH; Liu HR; Xu WB; Feng RE; Zhang ZH; Tian XL; Zhu YJ
    Respiration; 2009; 78(4):377-86. PubMed ID: 19390161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled double blind multicenter study of the effectiveness of 5-aminosalicylic acid in patients with Crohn's disease in remission.
    Arber N; Odes HS; Fireman Z; Lavie A; Broide E; Bujanover Y; Becker S; Pomerantz I; Moshkowitz M; Patz J
    J Clin Gastroenterol; 1995 Apr; 20(3):203-6. PubMed ID: 7797827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD).
    Bodolay E; Szekanecz Z; Dévényi K; Galuska L; Csípo I; Vègh J; Garai I; Szegedi G
    Rheumatology (Oxford); 2005 May; 44(5):656-61. PubMed ID: 15716315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of Crohn's disease with broncho-bronchiolitis].
    Kubota Y; Hosogi S; Iwasaki Y
    Nihon Kokyuki Gakkai Zasshi; 2004 Jul; 42(7):655-9. PubMed ID: 15357269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
    Sutherland LR; Martin F; Bailey RJ; Fedorak RN; Poleski M; Dallaire C; Rossman R; Saibil F; Lariviere L
    Gastroenterology; 1997 Apr; 112(4):1069-77. PubMed ID: 9097988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interstitial lung disease in systemic sclerosis.
    Bussone G; Mouthon L
    Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interstitial pneumonia treated with intermittent cyclophosphamide pulse therapy].
    Harada T; Takayama K; Kimotsuki K; Hidaka K; Miyazaki H; Kuwano K; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Nov; 34(11):1221-6. PubMed ID: 8976077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumothorax as a presenting feature of granulomatous disease of the lung in a patient with Crohn's disease.
    Smith PA; Crampton JR; Pritchard S; Li C
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):237-40. PubMed ID: 19212215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulomatous bronchiolitis associated with Crohn's disease.
    Vandenplas O; Casel S; Delos M; Trigaux JP; Melange M; Marchand E
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1676-9. PubMed ID: 9817724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of Crohn's disease that shows the improvement of the gastric disorder by the administration of mesalazine powder].
    Nagamata H; Torii A; Izumi M; Anami M; Yamashita N; Inadama E; Toda G
    Nihon Shokakibyo Gakkai Zasshi; 2000 Oct; 97(10):1261-6. PubMed ID: 11075590
    [No Abstract]   [Full Text] [Related]  

  • 39. Mesalazine-induced Pleuropericarditis in a Patient with Crohn's Disease.
    Kiyomatsu H; Kawai K; Tanaka T; Tanaka J; Kiyomatsu T; Nozawa H; Kanazawa T; Kazama S; Ishihara S; Yamaguchi H; Sunami E; Watanabe T
    Intern Med; 2015; 54(13):1605-8. PubMed ID: 26134190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe exudative ascites as an initial presentation of Crohn's disease.
    Tekin F; Vatansever S; Ozütemiz O; Musoğlu A; Ilter T
    Turk J Gastroenterol; 2005 Sep; 16(3):171-3. PubMed ID: 16245232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.